AAAS CEO Alan I. Leshner registers 'strong concerns' over suppression of science films

WASHINGTON, D.C.-The following letter was sent Monday 28 March 2005 to 410 members of the Association of Science-Technology Centers by Alan I Leshner, CEO of the American Association for the Advancement of Science and executive publisher of the journal Science. The letter was prompted by recent reports that Imax theaters in at least a dozen U.S. cities have declined to show films that endorse the science of evolution.

Dear Colleagues:

The American Association for the Advancement of Science (AAAS), the world's largest general scientific society, shares with science and technology centers and museums a deep commitment to improved public understanding of science and the role it plays in people's lives. We are writing now to express strong concerns about increasing threats to science that endanger our shared missions and to offer our support and partnership in dealing with them.

A March 19, 2005 New York Times article-"A New Test for Imax: The Bible vs. the Volcano," by Cornelia Dean-raised serious issues about the future of science and scientific freedom in America. The article, which detailed the growing trend of science museums declining to show Imax films that mention the process of evolution, explains that fear of protests has prompted some museum managers to scrub such offerings from play lists. The films include "Galapagos," about the islands where Darwin theorized about evolution; and "Volcanoes of the Deep Sea," a look at life in the super-heated world of deep-sea vents.

The desire not to antagonize audiences and to avoid negative business outcomes is entirely understandable. Yet, the suppression of scientifically accurate information as a response to those with differing perspectives is inappropriate and threatens both the integrity of science and the broader public education to which we all are committed. It is also objectionable to many stakeholders-including many with strong religious c


Page: 1 2

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research
4. AAAS CEO Alan I. Leshner statement on the UN cloning debate
5. New AAAS report cites serious concerns with electronic voting
6. Natural mechanism for immune suppression paves way for cancer trials
7. Oxidative stress stimulates p38 MAPK-mediated tumor suppression
8. Scripps Research study reveals new function of protein kinase pathway in tumor suppression
9. Transplant cures rats type 2 diabetes without need for immune suppression drugs
10. UCSF study shows suppression of telomerase enzyme can inhibit spread of melanoma
11. Wildfire suppression costs may be reduced using new model

Post Your Comments:

(Date:8/15/2017)... 2017   ivWatch LLC , a medical device company focused ... announced receipt of its ISO 13485 Certification, the global standard for ... for Standardization (ISO®). ... 400 Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 /PRNewswire/ ... leader in dairy research, today announced a new collaboration ... reduce the chances that the global milk supply is ... dairy project, Cornell University has become the newest academic ... Supply Chain, a food safety initiative that includes IBM ...
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... 10, 2017 , ... For the second time in three ... Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October ... US2020’s mission is to change the trajectory of STEM education in America by ...
Breaking Biology Technology:
Cached News: